LION POINT CAPITAL, LP

PrivateCIK: 1643354
Location

NEW YORK, NY

πŸ“‹ What this filing means

LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $14.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

19
Positions
$14.73M
Total AUM (reported)
2.99M
Total Shares

Allocation by class

TOTAL AUM$14.73M19 positions
COM$9.97M67.7%
COM NEW$1.54M10.4%
ORD SHS CL A$1.27M8.6%
COM PAR $.01$1.07M7.3%
COM SHS$873.5K5.9%

Portfolio Concentration

Top 328.6%4–1045.8%11–2525.7%TOP 1074.3%0%100%
Top 3$4.21M28.6%
4–10$6.74M45.8%
11–25$3.78M25.7%

Top 3 weight

28.6%

Top 10 weight

74.3%

Voting Authority Distribution

Total shares with voting rights: 2.99M

Sole

Full voting authority

2.99M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole19
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings19
Rows:

FENNEC PHARMACEUTICALS INC

SOLE
COM
Shares195.70K
TypeSH
Market value$1.62M
11.03%
Sole
195.70K
Shared
0.00
None
0.00

ARDELYX INC

SOLE
COM
Shares335.40K
TypeSH
Market value$1.31M
8.93%
Sole
335.40K
Shared
0.00
None
0.00

KINIKSA PHARMACEUTICALS INTL

SOLE
ORD SHS CL A
Shares45.90K
TypeSH
Market value$1.27M
8.62%
Sole
45.90K
Shared
0.00
None
0.00

BRIDGEBIO PHARMA INC

SOLE
COM
Shares26K
TypeSH
Market value$1.12M
7.62%
Sole
26K
Shared
0.00
None
0.00

INSMED INC

SOLE
COM PAR $.01
Shares10.65K
TypeSH
Market value$1.07M
7.28%
Sole
10.65K
Shared
0.00
None
0.00

MINERALYS THERAPEUTICS INC

SOLE
COM
Shares79K
TypeSH
Market value$1.07M
7.26%
Sole
79K
Shared
0.00
None
0.00

MILESTONE PHARMACEUTICALS IN

SOLE
COM
Shares548.81K
TypeSH
Market value$1.06M
7.23%
Sole
548.81K
Shared
0.00
None
0.00

AVADEL PHARMACEUTICALS PLC

SOLE
COM SHS
Shares98.70K
TypeSH
Market value$873.5K
5.93%
Sole
98.70K
Shared
0.00
None
0.00

JASPER THERAPEUTICS INC

SOLE
COM NEW
Shares146.50K
TypeSH
Market value$813.1K
5.52%
Sole
146.50K
Shared
0.00
None
0.00

BENITEC BIOPHARMA INC

SOLE
COM NEW
Shares62K
TypeSH
Market value$725.4K
4.93%
Sole
62K
Shared
0.00
None
0.00

GERON CORP

SOLE
COM
Shares500K
TypeSH
Market value$705.0K
4.79%
Sole
500K
Shared
0.00
None
0.00

ARCUTIS BIOTHERAPEUTICS INC

SOLE
COM
Shares46.30K
TypeSH
Market value$649.1K
4.41%
Sole
46.30K
Shared
0.00
None
0.00

DISC MEDICINE INC

SOLE
COM
Shares10.60K
TypeSH
Market value$561.4K
3.81%
Sole
10.60K
Shared
0.00
None
0.00

SYNDAX PHARMACEUTICALS INC

SOLE
COM
Shares55K
TypeSH
Market value$515.1K
3.50%
Sole
55K
Shared
0.00
None
0.00

REGENXBIO INC

SOLE
COM
Shares57.75K
TypeSH
Market value$474.1K
3.22%
Sole
57.75K
Shared
0.00
None
0.00

BIOHAVEN LTD

SOLE
COM
Shares22.70K
TypeSH
Market value$320.3K
2.17%
Sole
22.70K
Shared
0.00
None
0.00

MERSANA THERAPEUTICS INC

SOLE
COM
Shares644K
TypeSH
Market value$190.6K
1.29%
Sole
644K
Shared
0.00
None
0.00

SERES THERAPEUTICS INC

SOLE
COM
Shares17.04K
TypeSH
Market value$189.3K
1.29%
Sole
17.04K
Shared
0.00
None
0.00

HUMACYTE INC

SOLE
COM
Shares83.50K
TypeSH
Market value$174.5K
1.18%
Sole
83.50K
Shared
0.00
None
0.00
LION POINT CAPITAL, LP 13F Holdings β€” 19 Positions | Finecho